CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
androgen deprivation therapy (ADT) with a luteinising hormone releasing hormone analogue (LHRHA) in men having radiation therapy for localised prostate...
Phase 3
Commack, New York, United States and 92 other locations
pharmacodynamic (PD), and the preliminary efficacy of JANX007 administered as a single agent in adults with metastatic castration-resistant prostate...
Phase 1
New Haven, Connecticut, United States and 15 other locations
Cu 64 PSMA I\&T injection for PET/CT imaging in patients with newly diagnosed unfavorable intermediate high-risk, high-risk or very high-risk prostate...
Phase 3
Hawthorne, New York, United States and 34 other locations
Phase 1b study to assess the combination of ARV-110 and abiraterone in patients with metastatic prostate cancer with rising PSA val...
Phase 1
New Haven, Connecticut, United States and 17 other locations
Phase 1/2 dose escalation study to assess the safety and tolerability of ARV-110 in men with mCRPC who have progressed on prior approved systemic the...
Phase 1, Phase 2
New Haven, Connecticut, United States and 53 other locations
A Phase 1/2 study to evaluate the safety and efficacy of ARV-766 given by mouth alone or in combination with abiraterone in men with metastatic prostate...
Phase 1, Phase 2
New Haven, Connecticut, United States and 22 other locations
is a safe and effective way to treat previously untreated metastatic prostate cancer, and to see whether the study treatment works ...
Phase 2
Commack, New York, United States and 7 other locations
Evaluate the safety and tolerability of AMG 509 in adult participants and determine the maximum tolerated dose (MTD) or recommended phase 2 dose (RP2...
Phase 1
New Haven, Connecticut, United States and 50 other locations
to as AAA617. The study also seeks to further characterize (as possible) any other serious adverse reaction(s) in the long-term in adults with prostate...
Phase 4
Hartford, Connecticut, United States and 53 other locations
This study is comparing the safety and effectiveness of abiraterone acetate alone, followed by the addition of prednisone (when the participant's dis...
Phase 2
Commack, New York, United States and 7 other locations
Clinical trials
Research sites
Resources
Legal